Tag Archives: American Heart Association

AstraZeneca Reports Positive Phase III Bax24 Results, Reinforcing Baxdrostat’s Potential as a Novel Treatment for Hard-to-Control Hypertension

(IN BRIEF) AstraZeneca reported positive Phase III Bax24 trial results showing that baxdrostat achieved a significant and clinically meaningful reduction in 24-hour ambulatory systolic blood pressure in patients with treatment-resistant hypertension. The once-daily oral therapy was well tolerated and maintained … Read the full press release

Global Cardiovascular Disease Taskforce calls to world leaders to continue the progress made on addressing non-communicable diseases (NCDs) and CVD

Leaders in cardiovascular disease prevention and control publish follow up paper applauding action and calling for the CVD community to continue its leadership to reduce premature mortality by 25 percent by 2025 Geneva, 25-9-2013 — /EuropaWire/ — In celebration of the … Read the full press release